Literature DB >> 21333492

Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes.

E I Kampylafka1, J G Routsias, H Alexopoulos, M C Dalakas, H M Moutsopoulos, A G Tzioufas.   

Abstract

The autoantibody to aquaporin-4 (AQP4) is a marker and a pathogenetic factor in Neuromyelitis Optica (NMO) (Devic's syndrome). Our aim was to identify B-cell antigenic linear epitopes of the AQP4 protein and investigate similarities with other molecules. To this end, we screened sera from 21 patients positive for anti-AQP4 antibodies (study group), from 23 SLE and 23 pSS patients without neurologic involvement (disease controls) and from 28 healthy individuals (normal controls). Eleven peptides, spanning the entire intracellular and extracellular domains of the AQP4 molecule, were synthesized, and all sera were screened for anti-peptide antibodies by ELISA. Specificity was evaluated by homologous inhibition assays. NMO positive sera exhibited reactivity against 3 different peptides spanning the sequences aa1-22 (AQPpep1) (42.9% of patients), aa88-113 (AQPpep4) (33%) and aa252-275 (AQPpep8) (23.8%). All epitopes were localized in the intracellular domains of AQP4. Homologous inhibition rates were ranging from 71.1% to 84.3%. A 73% sequence homology was observed between AQPpep8' aa257-271, a 15-mer peptide part of the AQPpep8 aa252-275, and the aa219-233 domain of the Tax1-HTLV-1 binding protein (TAX1BP1), a host protein associated with replication of the Human T-Lymphotropic Virus 1 (HTLV-1). Antibodies against the AQP4 and the TAX1BP1 15-mer peptides were detected in 26.3% (N = 5) and 31.6% (N = 6) of NMO positive sera (r(s) = 0.81, P < 0.0001). Healthy controls did not react with these peptides, while homologous and cross-inhibition assays confirmed binding specificity. This first epitope mapping for AQP4 reveals that a significant proportion of anti-AQP4 antibodies target linear epitopes localized in the intracellular domains of the channel. One of the epitopes displays high similarity with a portion of TAX1BP1 protein.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333492     DOI: 10.1016/j.jaut.2011.01.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  17 in total

1.  Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Authors:  Burcu Ayoglu; Nicholas Mitsios; Ingrid Kockum; Mohsen Khademi; Arash Zandian; Ronald Sjöberg; Björn Forsström; Johan Bredenberg; Izaura Lima Bomfim; Erik Holmgren; Hans Grönlund; André Ortlieb Guerreiro-Cacais; Nada Abdelmagid; Mathias Uhlén; Tim Waterboer; Lars Alfredsson; Jan Mulder; Jochen M Schwenk; Tomas Olsson; Peter Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-09       Impact factor: 11.205

2.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

3.  Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy.

Authors:  Mkael Symmonds; Niranjanan Nirmalananthan; Graham P Taylor; Leslie R Bridges; Frederick Schon
Journal:  J Neurol       Date:  2012-08-24       Impact factor: 4.849

Review 4.  Guillain-Barré syndrome: expanding the concept of molecular mimicry.

Authors:  Jon D Laman; Ruth Huizinga; Geert-Jan Boons; Bart C Jacobs
Journal:  Trends Immunol       Date:  2022-03-04       Impact factor: 19.709

5.  Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.

Authors:  Raffaele Iorio; James P Fryer; Shannon R Hinson; Petra Fallier-Becker; Hartwig Wolburg; Sean J Pittock; Vanda A Lennon
Journal:  J Autoimmun       Date:  2012-08-18       Impact factor: 7.094

6.  Aquaporin 4 molecular mimicry and implications for neuromyelitis optica.

Authors:  Radhika A Vaishnav; Ruolan Liu; Joab Chapman; Andrew M Roberts; Hong Ye; Jovan D Rebolledo-Mendez; Takeshi Tabira; Alicia H Fitzpatrick; Anat Achiron; Mark P Running; Robert P Friedland
Journal:  J Neuroimmunol       Date:  2013-05-09       Impact factor: 3.478

7.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

8.  Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.

Authors:  Gregory P Owens; Alanna Ritchie; Andrea Rossi; Kristin Schaller; Scott Wemlinger; Hannah Schumann; Andrew Shearer; Alan S Verkman; Jeffrey L Bennett
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

9.  Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.

Authors:  Francesco Pisani; Paolo Settanni; Stefania Rosito; Maria Grazia Mola; Raffaele Iorio; Carla Tortorella; Maddalena Ruggieri; Maria Trojano; Maria Svelto; Antonio Frigeri; Grazia Paola Nicchia
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

10.  Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.

Authors:  Maria M Dimitriadou; Haris Alexopoulos; Sofia Akrivou; Eleni Gola; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.